The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...

Former U.S. Patent and Trademark Office (USPTO) Director Kathi Vidal, now with Winston & Strawn, filed an amicus brief on Wednesday in an appeal to the U.S. Court of Appeals for the Federal ...

6,14 The site of the shunting, whether cardiac as through a patent foramen ovale or whether pulmonary as through precapillary anastomoses or whether through both sites, remains to be elucidated.